Comparative genomic hybridization analysis of human parathyroid tumors.
Primary hyperparathyroidism is characterized by hypercalcemia and elevated parathyroid hormone levels. It can be caused by overactivity of one (adenoma or carcinoma) or more (hyperplasia or multiple adenoma) parathyroid glands. Parathyroid adenoma and hyperplasia are usually mono- or oligoclonal neoplasms. To establish whether parathyroid cancer has a genetic composition distinct from parathyroid adenoma, we analyzed 10 adenoma and 10 carcinoma cases by comparative genomic hybridization (CGH). Results show clear differences between the constitution of adenoma and carcinoma genomic DNA. The most frequent genomic alterations in adenoma included deletions on chromosomes 11, 17 (5 of 10 cases), and 22 (7 of 10 cases). In parathyroid carcinoma, frequent chromosomal deletions were on chromosome arm 1p (4 of 10 cases) and chromosome 17 (3 of 10 cases), and gains were on chromosome 5 (3 of 10 cases). Our data indicate that different genetic changes could contribute to the development of parathyroid adenoma and carcinoma; genomic losses predominate in adenoma, and gains along with some losses are found in carcinoma. Furthermore, the CGH results implicate several chromosomal regions that may harbor genes that could be potentially involved in the development of parathyroid adenoma and carcinoma.
Genetics and Endocrinology Section, NIH, NIDDK, Bethesda, Maryland, USA.
S K
SK
Agarwal
E
E
Schröck
M B
MB
Kester
A L
AL
Burns
C S
CS
Heffess
T
T
Ried
S J
SJ
Marx
D000236:Adenoma / Q000235:genetics*; D002277:Carcinoma / Q000235:genetics*; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D010282:Parathyroid Neoplasms / Q000235:genetics*